Skip to main content

Table 1 Patient demographics and clinical outcomes of patients with small cell and non-small lung cancer

From: Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment

Patient characteristics  
Age, median (range) 64 years (42–77)
Gender 60 % male
Smoking status 29 % current smokers
Tumour type  
 SCLC 7 (28 %)
 NSCLC 18 (72 %)
Stage  
 I 3
 II 4
 III 18
Median DFS (range) 17 months (8–25)
2 year overall survival 53 %